Mohyuddin, G. R., Chakraborty, R., & Cliff, E. R. S. (2023). The promise and harms of screening for plasma cell dyscrasias. British Journal of Haematology, 200(6), 704–707. Portico. https://doi.org/10.1111/bjh.18634

Cicero, K. I., Joffe, M., Patel, M., Chiuzan, C., Pentz, A., Ruff, P., Lentzsch, S., Leng, S., Jacobson, J. S., Rebbeck, T. R., & Neugut, A. I. (2022). Prevalence of Monoclonal Gammopathy of Undetermined Significance in Black South African Men. Cancer Epidemiology, Biomarkers & Prevention, 31(12), 2192–2198. https://doi.org/10.1158/1055-9965.epi-22-0525

Chakraborty, R., Bhutani, D., & Lentzsch, S. (2022). How do we manage t(11;14) plasma cell disorders with venetoclax? British Journal of Haematology, 199(1), 31–39. Portico. https://doi.org/10.1111/bjh.18243

Javaugue, V., Valeri, A. M., Jaffer Sathick, I., Said, S. M., Erdogan Damgard, S., Murray, D. L., Klobucher, T., Andeen, N. K., Sethi, S., Fervenza, F. C., Leung, N., & Nasr, S. H. (2022). The characteristics of seronegative and seropositive non-hepatitis-associated cryoglobulinemic glomerulonephritis. Kidney International, 102(2), 382–394. https://doi.org/10.1016/j.kint.2022.03.030

Keren, D. F., Bocsi, G., Billman, B. L., Etzell, J., Faix, J. D., Kumar, S., Lipe, B., McCudden, C., Montgomery, R., Murray, D. L., Rai, A. J., Redondo, T. C., Souter, L., Ventura, C. B., & Ansari, M. Q. (2021). Laboratory Detection and Initial Diagnosis of Monoclonal Gammopathies. Archives of Pathology & Laboratory Medicine, 146(5), 575–590. https://doi.org/10.5858/arpa.2020-0794-cp